Profile data is unavailable for this security.
About the company
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
- Revenue in USD (TTM)1.78bn
- Net income in USD164.40m
- Incorporated2021
- Employees1.64k
- LocationHims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
- Phone+1 (415) 851-0195
- Fax+1 (302) 655-5049
- Websitehttps://www.forhims.com/
Mergers & acquisitions
| Acquired company | HIMS:NYQ since announced | Transaction value |
|---|---|---|
| Zava Global Gmbh | -8.35% | -- |
| C S Bio Co-Peptide Facility | 39.57% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp | 2.49bn | 308.74m | 6.73bn | 15.70k | 22.40 | 5.67 | 18.09 | 2.70 | 20.53 | 20.53 | 165.47 | 81.09 | 1.44 | 175.37 | 10.75 | 158,585.30 | 17.88 | 19.20 | 21.43 | 24.05 | 34.82 | 35.20 | 12.40 | 12.78 | 1.70 | -- | 0.0004 | 8.19 | 7.37 | 4.63 | 10.82 | 6.55 | -1.35 | 7.74 |
| Ensign Group Inc | 4.42bn | 309.42m | 8.28bn | 39.30k | 27.17 | 4.30 | 20.77 | 1.87 | 5.30 | 5.30 | 75.76 | 33.48 | 0.9756 | -- | 8.02 | 112,553.50 | 6.83 | 6.66 | 8.11 | 8.11 | 21.32 | 22.30 | 7.00 | 6.87 | -- | -- | 0.0697 | 5.65 | 14.24 | 15.91 | 42.30 | 26.58 | -5.78 | 4.78 |
| Hims & Hers Health Inc | 1.78bn | 164.40m | 10.72bn | 1.64k | 70.03 | 19.49 | 57.37 | 6.01 | 0.6839 | 0.6839 | 7.40 | 2.46 | 2.66 | 7.73 | 267.34 | 1,090,014.00 | 24.54 | -3.91 | 34.03 | -4.74 | 77.04 | -- | 9.21 | -2.35 | 1.32 | -- | 0.00 | -- | 69.33 | -- | 635.28 | 155.96 | -- | -- |
| Davita Inc | 12.97bn | 859.61m | 10.76bn | 76.00k | 14.11 | -- | 5.69 | 0.8299 | 10.10 | 10.10 | 152.64 | -3.46 | 0.7507 | 59.12 | 5.28 | 170,638.50 | 6.81 | 6.09 | 9.26 | 8.06 | 32.46 | 31.21 | 9.08 | 8.69 | 1.20 | 4.05 | 0.8544 | -- | 5.56 | 2.39 | 35.40 | 5.82 | -6.24 | -- |
| Universal Health Services Inc | 16.08bn | 1.20bn | 11.76bn | 86.00k | 10.25 | 1.73 | 6.49 | 0.7313 | 17.81 | 17.81 | 239.04 | 105.30 | 1.11 | -- | 6.83 | 187,024.10 | 8.43 | 6.68 | 10.01 | 7.94 | -- | -- | 7.58 | 6.62 | 1.23 | 9.84 | 0.4031 | 5.63 | 10.82 | 6.82 | 59.17 | 7.04 | 7.56 | 5.92 |
| Encompass Health Corp | 5.51bn | 494.00m | 11.96bn | 23.56k | 24.48 | 5.52 | 12.39 | 2.17 | 4.84 | 4.82 | 53.99 | 21.44 | 0.8565 | -- | 8.87 | 233,941.60 | 10.20 | 6.72 | 13.26 | 8.39 | 95.60 | 95.41 | 11.91 | 9.53 | -- | 7.09 | 0.457 | 26.04 | 11.91 | 3.13 | 26.02 | 4.94 | 9.72 | -10.27 |
| Molina Healthcare Inc | 41.87bn | 1.18bn | 12.01bn | 18.00k | 10.70 | 2.78 | 8.80 | 0.2868 | 20.70 | 20.70 | 737.08 | 79.81 | 2.62 | -- | 12.24 | 2,325,889.00 | 7.37 | 7.30 | 15.44 | 15.96 | 15.22 | 15.66 | 2.81 | 2.86 | -- | 12.81 | 0.4663 | 0.00 | 19.31 | 19.29 | 8.07 | 9.85 | 11.90 | -- |
| Centene Corp | 169.28bn | 3.45bn | 15.64bn | 60.50k | 4.68 | 0.5603 | 3.33 | 0.0924 | 6.72 | 6.72 | 329.55 | 56.11 | 2.00 | -- | 8.62 | 2,798,083.00 | 4.07 | 2.79 | 6.93 | 4.42 | 10.27 | 11.27 | 2.04 | 1.48 | -- | 5.26 | 0.3954 | 0.00 | 5.89 | 16.92 | 22.32 | 20.13 | -2.48 | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2025 | 21.80m | 10.20% |
| The Vanguard Group, Inc.as of 31 Mar 2025 | 18.02m | 8.43% |
| Farallon Capital Management LLCas of 31 Mar 2025 | 7.95m | 3.72% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2025 | 7.72m | 3.61% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 7.44m | 3.48% |
| Renaissance Technologies LLCas of 31 Mar 2025 | 7.02m | 3.29% |
| D. E. Shaw & Co. LPas of 31 Mar 2025 | 6.03m | 2.82% |
| Geode Capital Management LLCas of 31 Mar 2025 | 4.67m | 2.19% |
| SRS Investment Management LLCas of 31 Mar 2025 | 4.00m | 1.87% |
| Morgan Stanley & Co. LLCas of 31 Mar 2025 | 3.53m | 1.65% |
